(GBLB) Groep Brussel Lambert - Ratings and Ratios

Exchange: BR • Country: Belgium • Currency: EUR • Type: Common Stock • ISIN: BE0003797140

GBLB: Industrial, Consumer Goods, Business Services

Groupe Bruxelles Lambert SA is a diversified investment company with a portfolio that spans multiple sectors, including industrial, consumer goods, and business services. The company's investments are spread across various geographic regions, including Belgium, other European countries, North America, and international markets. This diversified approach allows the company to mitigate risk and capitalize on growth opportunities in different parts of the world. The company's portfolio is comprised of a range of companies operating in distinct sectors, providing a broad-based foundation for its investment activities.

The company's operations are organized into seven distinct segments, each with its own focus and strategy. The Holding segment serves as the core of the company's operations, overseeing the overall investment portfolio and providing strategic direction. Imerys is a leading manufacturer of mineral-based specialty materials, while Webhelp is a prominent provider of business process outsourcing services. Canyon and Affidea operate in the healthcare sector, with Canyon focused on medical equipment and Affidea providing diagnostic imaging services. Sanoptis is a healthcare company that offers a range of medical services, and GBL Capital and Sienna Investment Managers comprise the company's investment management arm, responsible for managing the company's investment portfolio and providing investment advisory services.

Groupe Bruxelles Lambert SA has a long history, dating back to its incorporation in 1902. The company is headquartered in Brussels, Belgium, and has established itself as a major player in the European investment landscape. With a strong track record of investing in a range of industries and sectors, the company has built a reputation for its disciplined investment approach and commitment to long-term value creation. The company's common stock is listed on the Euronext Brussels stock exchange, and its ISIN code is BE0003797140. As a multi-sector holdings company, Groupe Bruxelles Lambert SA is classified under the GICS Sub Industry category, reflecting its diversified investment portfolio and broad-based investment strategy.

The company's website, https://www.gbl.be, provides detailed information on its investment portfolio, company history, and governance structure. With a strong focus on transparency and accountability, the company provides regular updates on its financial performance and investment activities, allowing stakeholders to stay informed about its progress and strategic direction. As a leading investment company in Europe, Groupe Bruxelles Lambert SA is committed to delivering long-term value to its shareholders and stakeholders, while maintaining its position as a responsible and engaged corporate citizen.

Additional Sources for GBLB Stock

Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle

GBLB Stock Overview

Market Cap in USD 8,481m
Sector Financial Services
Industry Asset Management
GiC Sub-Industry Multi-Sector Holdings
IPO / Inception

GBLB Stock Ratings

Growth 5y -27.2%
Fundamental 48.3%
Dividend 39.7%
Rel. Strength Industry -97
Analysts -
Fair Price Momentum 63.30 EUR
Fair Price DCF 75.84 EUR

GBLB Dividends

Dividend Yield 12m 4.16%
Yield on Cost 5y 3.45%
Annual Growth 5y -2.68%
Payout Consistency 98.6%

GBLB Growth Ratios

Growth Correlation 3m -25%
Growth Correlation 12m -26.6%
Growth Correlation 5y -25.8%
CAGR 5y -3.60%
CAGR/Mean DD 5y -0.20
Sharpe Ratio 12m -0.49
Alpha -21.30
Beta 0.63
Volatility 14.69%
Current Volume 85.9k
Average Volume 20d 99.3k
What is the price of GBLB stocks?
As of January 22, 2025, the stock is trading at EUR 66.15 with a total of 85,855 shares traded.
Over the past week, the price has changed by +1.61%, over one month by +2.40%, over three months by -4.61% and over the past year by +1.06%.
Is Groep Brussel Lambert a good stock to buy?
Partly, yes. Based on ValueRay Fundamental Analyses, Groep Brussel Lambert (BR:GBLB) is currently (January 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 48.27 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of GBLB as of January 2025 is 63.30. This means that GBLB is currently overvalued and has a potential downside of -4.31%.
Is GBLB a buy, sell or hold?
Groep Brussel Lambert has no consensus analysts rating.
What are the forecast for GBLB stock price target?
According to ValueRays Forecast Model, GBLB Groep Brussel Lambert will be worth about 68.4 in January 2026. The stock is currently trading at 66.15. This means that the stock has a potential upside of +3.34%.
Issuer Forecast Upside
Wallstreet Target Price 89.8 35.8%
Analysts Target Price - -
ValueRay Target Price 68.4 3.3%